Association of IFNAR2 and TYK2 with COVID-19 pathology: current and future.
作者信息
Razavi Alireza, Raei Maedeh, Shirato Ken
机构信息
Student Research Committee, School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran.
Research Center for Clinical Virology, Tehran University of Medical Science, Tehran, Iran.
出版信息
Front Immunol. 2024 Sep 16;15:1462628. doi: 10.3389/fimmu.2024.1462628. eCollection 2024.
Abstract
摘要
相似文献
1
Association of IFNAR2 and TYK2 with COVID-19 pathology: current and future.
Front Immunol. 2024 Sep 16;15:1462628. doi: 10.3389/fimmu.2024.1462628. eCollection 2024.
2
Evaluation of IFNAR2 and TYK2 transcripts' prognostic role in COVID-19 patients: a retrospective study.
Front Cell Infect Microbiol. 2024 Apr 29;14:1356542. doi: 10.3389/fcimb.2024.1356542. eCollection 2024.
3
Expression analysis of IFNAR1 and TYK2 transcripts in COVID-19 patients.
Cytokine. 2022 May;153:155849. doi: 10.1016/j.cyto.2022.155849. Epub 2022 Mar 4.
4
TYK2, IFITM3, IFNAR2 and OAS3 single-nucleotide polymorphisms among severe COVID-19 ICU patients in Morocco.
Int J Immunopathol Pharmacol. 2024 Jan-Dec;38:3946320241257241. doi: 10.1177/03946320241257241.
5
Polymorphisms in , , , , and Genes Are Associated with Worse Clinical Outcomes in COVID-19.
Genes (Basel). 2022 Dec 22;14(1):29. doi: 10.3390/genes14010029.
6
Suppressor of cytokine signaling (SOCS) 1 inhibits type I interferon (IFN) signaling via the interferon alpha receptor (IFNAR1)-associated tyrosine kinase Tyk2.
J Biol Chem. 2011 Sep 30;286(39):33811-8. doi: 10.1074/jbc.M111.270207. Epub 2011 Jul 13.
7
Type I IFN receptor controls activated TYK2 in the nucleus: implications for EAE therapy.
J Neuroimmunol. 2013 Jan 15;254(1-2):101-9. doi: 10.1016/j.jneuroim.2012.10.006. Epub 2012 Oct 27.
8
Basal ubiquitin-independent internalization of interferon alpha receptor is prevented by Tyk2-mediated masking of a linear endocytic motif.
J Biol Chem. 2008 Jul 4;283(27):18566-72. doi: 10.1074/jbc.M800991200. Epub 2008 May 12.
9
Janus kinase signaling as risk factor and therapeutic target for severe SARS-CoV-2 infection.
Eur J Immunol. 2021 May;51(5):1071-1075. doi: 10.1002/eji.202149173. Epub 2021 Mar 22.
10
Luteolin sensitizes the antiproliferative effect of interferon α/β by activation of Janus kinase/signal transducer and activator of transcription pathway signaling through protein kinase A-mediated inhibition of protein tyrosine phosphatase SHP-2 in cancer cells.
Cell Signal. 2014 Mar;26(3):619-28. doi: 10.1016/j.cellsig.2013.11.039. Epub 2013 Dec 12.
本文引用的文献
1
TYK2, IFITM3, IFNAR2 and OAS3 single-nucleotide polymorphisms among severe COVID-19 ICU patients in Morocco.
Int J Immunopathol Pharmacol. 2024 Jan-Dec;38:3946320241257241. doi: 10.1177/03946320241257241.
2
Evaluation of IFNAR2 and TYK2 transcripts' prognostic role in COVID-19 patients: a retrospective study.
Front Cell Infect Microbiol. 2024 Apr 29;14:1356542. doi: 10.3389/fcimb.2024.1356542. eCollection 2024.
3
Type I interferon pathway genetic variants in severe COVID-19.
Virus Res. 2024 Apr;342:199339. doi: 10.1016/j.virusres.2024.199339. Epub 2024 Feb 22.
4
Participation of Single-Nucleotide Variants in and in the Immune Response against SARS-CoV-2 Infection: A Systematic Review.
Pathogens. 2023 Nov 6;12(11):1320. doi: 10.3390/pathogens12111320.
5
A comprehensive review of ACE2, ACE1, TMPRSS2 and IFITM3 gene polymorphisms and their effect on the severity of COVID-19.
Adv Med Sci. 2023 Sep;68(2):450-463. doi: 10.1016/j.advms.2023.10.010. Epub 2023 Nov 3.
6
Association of rs2236757 and rs10735079 Polymorphisms with Susceptibility to COVID-19 Infection and Severity in Palestine.
Interdiscip Perspect Infect Dis. 2023 Sep 16;2023:9551163. doi: 10.1155/2023/9551163. eCollection 2023.
7
Understanding the pivotal roles of ACE2 in SARS-CoV-2 infection: from structure/function to therapeutic implication.
Egypt J Med Hum Genet. 2022;23(1):103. doi: 10.1186/s43042-022-00314-9. Epub 2022 Jun 19.
8
Enhanced inhibition of MHC-I expression by SARS-CoV-2 Omicron subvariants.
Proc Natl Acad Sci U S A. 2023 Apr 18;120(16):e2221652120. doi: 10.1073/pnas.2221652120. Epub 2023 Apr 10.
9
Association of IFNAR1 and IFNAR2 with COVID-19 severity.
Lancet Microbe. 2023 Jul;4(7):e487. doi: 10.1016/S2666-5247(23)00095-2. Epub 2023 Apr 4.
10
TYK2 single-nucleotide variants associated with the severity of COVID-19 disease.
Arch Virol. 2023 Mar 23;168(4):119. doi: 10.1007/s00705-023-05729-2.
Zotero 插件